查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1474893

MCED（多種癌症早期檢測）市場規模、佔有率、趨勢分析報告：按類型、最終用途、按地區、細分市場預測，2024-2030 年

Multi Cancer Early Detection Market Size, Share & Trends Analysis Report By Type (Liquid Biopsy, Gene Panel, LDT & Others), By End-use (Hospitals, Diagnostic Laboratories), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10個工作天內

價格

MCED（多種癌症早期檢測）市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球MCED（多種癌症早期檢測）市場規模將達到28.9億美元，2024年至2030年複合年成長率為16.61%。

需要提供有效的方法來早期檢測癌症，以便提供適當的治療，以及癌症盛行率的上升和多種疾病類型預計將推動市場成長。對早期檢測診斷的需求正在推動整個市場的發展，這有助於簡單的疾病管理並降低隨後的死亡率。

MCED（多發性癌症早期檢測）測試旨在即使患者沒有症狀也能檢測體內的腫瘤。同時評估多個訊號以確定您是否可能患有癌症。儘管已經開發出許多測試來早期檢測癌症，但 MCED篩檢測試直到最近才在美國成為第一個由實驗室開發的測試。例如，2022 年 7 月，GRAIL 的 Galleri 成為聖路易斯 Mercy 的 LDT。此外，Exact Sciences 和 Freenome 正在開發 MCED篩檢測試，而 GRAIL 的 Galleri 測試在銷售時沒有保險，因為能夠檢測多達 50 種不同的類型。

研究表明，MCED 測試在檢測晚期和晚期階段比早期階段更敏感，早期階段是可以治療的，有時是可以治癒的。此外，該測試被發現具有高度特異性，這意味著未患有癌症的人測試呈陽性的可能性極小。 MCED 開發領域的研究仍在繼續，以滿足早期診斷的需求。

市場上的領先公司聲稱他們可以識別從幾種癌症到 50 種癌症的任何類型。公司專注於發展和開發這些篩檢測試，並更快地將其推向市場。例如，2020 年 12 月，Singra Genomics 籌集了 1.5 億美元的 B 系列資金，用於開發、行銷和推廣其 MCED 測試。 GRAIL 與 Point32Health 開始了先導計畫，使 Point32Health 成為第一個包含 MCED 測試的商業健康計劃。

MCED（多種癌症早期檢測）市場報告亮點：

  • 基因panel、LDT等細分領域引領市場，2023年佔97.08%的佔有率。該領域的成長是由於診斷實驗室使用 LDT 不需要 FDA核准。
  • 預計液態切片領域在預測期內將以最快的複合年成長率成長。該細分市場的成長是由於越來越多的參與者從投資者那裡獲得資金用於開發新測試。
  • 2023 年，醫院終端用途領域以 48.44% 的佔有率引領市場。這是因為人們越來越傾向於住院治療，因為他們可以在同一屋簷下獲得各種服務。
  • 由於該地區癌症發生率高、技術進步快以及政府措施，2023 年北美多發性癌症早期檢測市場將佔 34.39% 的佔有率。
  • 由於醫療基礎設施的顯著改善、人口的成長以及進入市場的當地企業數量的增加，預計亞太地區 MCED（多發性癌症早期檢測）市場將在預測期內呈現最快的複合年成長率。

目錄

第1章 MCED（多發性癌症早期檢測）市場：調查方法與範圍

第 2 章 MCED（多發性癌症早期檢測）市場：執行摘要

  • 市場展望
  • 分部展望
  • 競爭考察

第3章 MCED（多發性癌症早期檢測）市場：產業展望

  • 市場體系展望
  • 市場動態
  • MCED（多種癌症早期檢測）市場分析工具

第4章 MCED（多發性癌症早期檢測）市場：類型估計和趨勢分析

  • 類型市場佔有率，2023年及2030年
  • 細分儀表板
  • 全球 MCED（多發性癌症早期檢測）市場：按類型分類的展望
  • 2018-2030年市場規模、預測及趨勢分析

第5章 MCED（多種癌症早期檢測）市場：最終用途估計和趨勢分析

  • 2023 年及 2030 年最終用途市場佔有率
  • 細分儀表板
  • 全球 MCED（多種癌症早期檢測）市場：按最終用途分類的前景
  • 2018-2030年市場規模、預測及趨勢分析

第6章 MCED（多發性癌症早期檢測）市場：區域估計和趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概述
  • 2018年至2030年市場規模、預測與趨勢分析
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • Illumina, Inc.（GRAIL, LLC）
    • Exact Sciences Corporation
    • FOUNDATION MEDICINE, INC.
    • AnchorDx
    • Guardant Health
    • Burning Rock Biotech Limited
    • GENECAST
    • Beijing Lyman Juntai International Medical Technology Development Co.
    • Freenome Holdings, Inc.
    • Elypta AB
Product Code: GVR-4-68039-966-1

Multi Cancer Early Detection Market Growth & Trends:

The global multi cancer early detection market size is expected to reach USD 2.89 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 16.61% from 2024 to 2030. The need for providing effective ways to detect cancer at an early stage so that the right treatment can be given and the rising prevalence of cancer and multiple forms are expected to fuel the growth of the market. The requirement for early detection diagnostics, which facilitates simple disease management and subsequently lowers the death rate, drives the overall market.

Multi cancer early detection (MCED) tests are designed to find tumors in the body even when a patient is asymptomatic. To determine whether there is a high probability that a person has cancer, they simultaneously evaluate several signals. Although numerous tests are being developed to detect cancer at an early stage, the first MCED screening test was just recently made available in the U.S. as a lab-developed test. For instance, in July 2022, GRAIL's Galleri was made available as an LDT at Mercy, St. Louis. Furthermore, MCED screening tests are being developed by Exact Sciences and Freenome, and GRAIL's Galleri test is being marketed without payer coverage with the claim that it can detect up to fifty different forms.

Studies show that MCED tests have a higher sensitivity for detecting later-stage or advanced than for detecting earlier stages, which are more treatable and occasionally curable. Additionally, it was found that the tests were highly specific, which made it extremely unlikely that they would give a positive result for someone who did not have cancer. To meet the demand for early diagnosis, ongoing research is still being done in the field of developing MCED.

The major players in the market assert that they can identify as few as two or three different cancer types or as many as fifty. They are focusing on the growth and development of these screening tests and faster commercialization. For instance, in December 2020, Singlera Genomics raised $150 million in Series B funding for the development, marketing, and promotion of its MCED tests. GRAIL launched a pilot project with Point32Health, making Point32Health the first commercial plan for health to include MCED tests.

Multi Cancer Early Detection Market Report Highlights:

  • The gene panel, LDT, & others segment led the market and accounted for a share of 97.08% in 2023. The growth of the segment is attributed to the non-requirement of FDA approval for the utilization of LDT in diagnostic laboratories.
  • The liquid biopsy segment is anticipated to grow at the fastest CAGR over the forecast period. The growth of this segment is attributed to the increasing number of players receiving funding from investors for the development of new tests.
  • The hospitals end-use segment led the market with a share of 48.44% in 2023. This is attributed to the growing preference of hospitals for care due to the availability of various services under one roof.
  • The North America multi cancer early detection market accounted for a share of 34.39% in 2023 owing to high cancer prevalence, rapid technological advancements, and the presence of various supportive government initiatives in the region.
  • Asia Pacific multi cancer early detection market is anticipated to witness the fastest CAGR over the forecast period due to a significantly improving healthcare infrastructure, a growing population, and a rising number of local companies entering the market.

Table of Contents

Chapter 1. Multi Cancer Early Detection Market: Methodology And Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End-Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Multi Cancer Early Detection Market: Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End-Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Multi Cancer Early Detection Market: Industry Outlook

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of cancer
      • 3.2.1.2. Extensive R&D for the development of MCED
      • 3.2.1.3. Need to develop diagnostic options that can detect cancer at an early stage
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Collection of adequate safety and efficacy data for regulatory approval
  • 3.3. Multi Cancer Early Detection (MCED) Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Multi Cancer Early Detection (MCED) Market: Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Multi Cancer Early Detection (MCED) Market by Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Liquid Biopsy
      • 4.4.1.1. Liquid biopsy market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Gene Panel, LDT, and Others
      • 4.4.2.1. Gene panel, LDT, and others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Multi Cancer Early Detection (MCED) Market: End-use Estimates & Trend Analysis

  • 5.1. End-Use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Multi Cancer Early Detection (MCED) Market by End-use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Hospitals
      • 5.4.1.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Diagnostic Laboratories
      • 5.4.2.1. Diagnostic laboratories market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Other
      • 5.4.3.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Multi Cancer Early Detection (MCED) Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Illumina, Inc. (GRAIL, LLC)
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Exact Sciences Corporation
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. FOUNDATION MEDICINE, INC.
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. AnchorDx
      • 7.3.7.1. Company overview
      • 7.3.7.2. Product benchmarking
      • 7.3.7.3. Strategic initiatives
    • 7.3.8. Guardant Health
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Burning Rock Biotech Limited
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. GENECAST
      • 7.3.10.1. Company overview
      • 7.3.10.2. Product benchmarking
      • 7.3.10.3. Strategic initiatives
    • 7.3.11. Beijing Lyman Juntai International Medical Technology Development Co.
      • 7.3.11.1. Company overview
      • 7.3.11.2. Product benchmarking
      • 7.3.11.3. Strategic initiatives
    • 7.3.12. Freenome Holdings, Inc.
      • 7.3.12.1. Company overview
      • 7.3.12.2. Product benchmarking
      • 7.3.12.3. Strategic initiatives
    • 7.3.13. Elypta AB
      • 7.3.13.1. Company overview
      • 7.3.13.2. Product benchmarking
      • 7.3.13.3. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America multi cancer early detection market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 U.S. multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 8 Canada multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Europe multi cancer early detection market, by region, 2018 - 2030 (USD Million)
  • Table 10 Europe multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 11 Europe multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Germany multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 13 Germany multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 UK multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 15 UK multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 France multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 17 France multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Italy multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 19 Italy multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Spain multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 21 Spain multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Denmark multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 23 Denmark multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Sweden multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 25 Sweden multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Norway multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 27 Norway multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific multi cancer early detection market, by region, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 China multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 32 China multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Japan multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 34 Japan multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 India multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 36 India multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 South Korea multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 38 South Korea multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Australia multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 40 Australia multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Thailand multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 42 Thailand multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Latin America multi cancer early detection market, by region, 2018 - 2030 (USD Million)
  • Table 44 Latin America multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 45 Latin America multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Brazil multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 47 Brazil multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Mexico multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 49 Mexico multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Argentina multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 51 Argentina multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 MEA multi cancer early detection market, by region, 2018 - 2030 (USD Million)
  • Table 53 MEA multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 54 MEA multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 South Africa multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 56 South Africa multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 UAE multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 60 UAE multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Multi cancer early detection market: market outlook
  • Fig. 14 Tumor ablation competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Multi cancer early detection market driver impact
  • Fig. 20 Multi cancer early detection market restraint impact
  • Fig. 21 Multi cancer early detection market strategic initiatives analysis
  • Fig. 22 Multi cancer early detection market: Type movement analysis
  • Fig. 23 Multi cancer early detection market: Type outlook and key takeaways
  • Fig. 24 Liquid biopsy market estimates and forecast, 2018 - 2030
  • Fig. 25 Gene panel, LDT, & others estimates and forecast, 2018 - 2030
  • Fig. 26 Multi cancer early detection market: End-Use movement Analysis
  • Fig. 27 Multi cancer early detection market: End-Use outlook and key takeaways
  • Fig. 28 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 29 Diagnostic laboratories market estimates and forecasts,2018 - 2030
  • Fig. 30 Others market estimates and forecasts,2018 - 2030
  • Fig. 31 Global multi cancer early detection market: Regional movement analysis
  • Fig. 32 Global multi cancer early detection market: Regional outlook and key takeaways
  • Fig. 33 Global multi cancer early detection market share and leading players
  • Fig. 34 North America market share and leading players
  • Fig. 35 Europe market share and leading players
  • Fig. 36 Asia Pacific market share and leading players
  • Fig. 37 Latin America market share and leading players
  • Fig. 38 Middle East & Africa market share and leading players
  • Fig. 39 North America: SWOT
  • Fig. 40 Europe SWOT
  • Fig. 41 Asia Pacific SWOT
  • Fig. 42 Latin America SWOT
  • Fig. 43 MEA SWOT
  • Fig. 44 North America market estimates and forecasts, 2018 - 2030
  • Fig. 45 U.S. key country dynamics
  • Fig. 46 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 47 Canada key country dynamics
  • Fig. 48 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 49 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 50 UK key country dynamics
  • Fig. 51 UK market estimates and forecasts, 2018 - 2030
  • Fig. 52 Germany key country dynamics
  • Fig. 53 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 54 France key country dynamics
  • Fig. 55 France market estimates and forecasts, 2018 - 2030
  • Fig. 56 Italy key country dynamics
  • Fig. 57 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 58 Spain key country dynamics
  • Fig. 59 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 60 Denmark key country dynamics
  • Fig. 61 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 62 Sweden key country dynamics
  • Fig. 63 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 64 Norway key country dynamics
  • Fig. 65 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 66 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 67 China key country dynamics
  • Fig. 68 China market estimates and forecasts, 2018 - 2030
  • Fig. 69 Japan key country dynamics
  • Fig. 70 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 71 India key country dynamics
  • Fig. 72 India market estimates and forecasts, 2018 - 2030
  • Fig. 73 Thailand key country dynamics
  • Fig. 74 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 75 South Korea key country dynamics
  • Fig. 76 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 77 Australia key country dynamics
  • Fig. 78 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 79 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 80 Brazil key country dynamics
  • Fig. 81 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 82 Mexico key country dynamics
  • Fig. 83 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 84 Argentina key country dynamics
  • Fig. 85 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 86 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 87 South Africa key country dynamics
  • Fig. 88 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 89 Saudi Arabia key country dynamics
  • Fig. 90 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 91 UAE key country dynamics
  • Fig. 92 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 93 Kuwait key country dynamics
  • Fig. 94 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 95 Market share of key market players- Multi cancer early detection market